Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
The main purpose of this study is to establish an optimal monitoring regimen in NutropinAq
 treated children, using newly developed capillary blood spot IGF-1 measurement technology.
Inclusion Criteria:

 -  Children under 18 with growth failure associated with inadequate growth hormone
 secretion, or Turner syndrome or chronic renal insufficiency.

 Exclusion Criteria:

 -  Children with closed epiphyses

 -  Children with active neoplasm

 -  Children with acute critical illness